David H. Crean, managing director for Objective Capital Partners, highlights the progress that has been made over the past year in investments in…

In the light of several recent regulatory updates to Canada’s cannabis laws, lawyer Jean-Raphaël Champagne examines the potential for cannabis to…

Peter Homberg of Dentons Germany examines the regulatory status quo around the free sale of products containing cannabidiol (CBD) across Europe.…

OPINION: Keith Wolsko and Danielle Moore of cannabis industry recruitment specialists Simply Kind Solutions highlight the seismic recent growth of the…

Saul Kaye of iCAN and CannaTech outlines a compelling case for Israel to be considered one of the world's leading hostpots for medical cannabis;…

This week the Korean Ministry of Food and Drug Safety announced that as of 12th March 2019 a revised narcotics bill will go into effect that will…

Founded in 1998, GW Pharmaceuticals is a British biopharmaceutical company, best known for being the only company with a license to cultivate cannabis…

Unclear licensing rules raise concerns that big foreign firms applying for patents might squeeze out local players and drive up the cost of…

With an increasing number of NFL players relying on potentially dangerous prescription painkillers, does the league need to relax its attitude to…

Southeast Asia’s notoriously strict anti-cannabis laws could be set to relax dramatically as South Korea becomes the first country in the region to…

Lawyer Joana Silveira Botelho provides regular legal assistance to pharmaceutical companies and other entities of the health sector. Here she examines…

John Fowler founded 7ACRES, a licensed producer of cannabis, in 2013. In 2014, 7ACRES went over to become part of The Supreme Cannabis Company, which…